I agree that this site is using cookies. You can find further informations here.
X
Lafferty, Ryan
153  results:
Search for persons X
?
1

Novel enzyme‐resistant pancreatic polypeptide analogs evoke..:

Zhu, Wuyun ; Tanday, Neil ; Lafferty, Ryan A...
BioFactors.  , 2024
Link: https://doi.org/10.1002/..
 
?
2

NPYR modulation: Potential for the next major advance in ob..:

Lafferty, Ryan A. ; Flatt, Peter R. ; Irwin, Nigel
Peptides.  179 (2024)  - p. 171256 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Purification and characterization of multifunctional peptid..:

Shekoohi, Niloofar ; Harnedy-Rothwell, Pádraigín ; Sharkey, Shaun...
Journal of Functional Foods.  116 (2024)  - p. 106173 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Does glucose-dependent insulinotropic polypeptide receptor ..:

Lafferty, Ryan A ; Flatt, Peter R ; Gault, Victor A.
Journal of Endocrinology.  262 (2024)  2 - p. , 2024
Link: https://doi.org/10.1530/..
 
?
5

Antidiabetic actions of GPR55 agonist Abn-CBD and sitaglipt..:

McCloskey, Andrew G. ; Miskelly, Michael G. ; Lafferty, Ryan A...
Biochemical Pharmacology.  208 (2023)  - p. 115398 , 2023
Link: https://doi.org/10.1016/..
 
?
6

GLP-1/GIP analogs: potential impact in the landscape of obe..:

Lafferty, Ryan A. ; Flatt, Peter R. ; Irwin, Nigel
Expert Opinion on Pharmacotherapy.  24 (2023)  5 - p. 587-597 , 2023
Link: https://doi.org/10.1080/..
 
?
7

The glucagon receptor antagonist desHis1Pro4Glu9-glucagon(L..:

Lafferty, Ryan ; Tanday, Neil ; Dubey, Vaibhav...
Molecular and Cellular Endocrinology.  570 (2023)  - p. 111932 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Sustained glucagon receptor antagonism in insulin-deficient..:

Lafferty, Ryan A ; McShane, Laura M ; Franklin, Zara J...
Journal of Endocrinology.  255 (2022)  2 - p. 91-101 , 2022
Link: https://doi.org/10.1530/..
 
?
9

Metabolic effects of combined glucagon receptor antagonism ..:

Franklin, Zara J. ; Lafferty, Ryan A. ; Flatt, Peter R....
Biochimie.  199 (2022)  - p. 60-67 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Beneficial metabolic effects of recurrent periods of beta‐c..:

Tanday, Neil ; Lafferty, Ryan A. ; Flatt, Peter R..
Diabetes, Obesity and Metabolism.  24 (2022)  12 - p. 2353-2363 , 2022
Link: https://doi.org/10.1111/..
 
?
11

Ac3IV, a V1a and V1b receptor selective vasopressin analogu..:

Mohan, Shruti ; Lafferty, Ryan A. ; Flatt, Peter R...
Peptides.  152 (2022)  - p. 170772 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Is polypharmacy the future for pharmacological management o..:

Lafferty, Ryan A. ; Flatt, Peter R. ; Irwin, Nigel
Current Opinion in Endocrine and Metabolic Research.  23 (2022)  - p. 100322 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Effects of artemether on pancreatic islet morphology, islet..:

Sarnobat, Dipak ; Lafferty, Ryan A ; Charlotte Moffett, R...
Journal of Pharmacy and Pharmacology.  74 (2022)  12 - p. 1758-1764 , 2022
Link: https://doi.org/10.1093/..
 
?
14

Positive Effects of NPY1 Receptor Activation on Islet Struc..:

Lafferty, Ryan A. ; Tanday, Neil ; Moffett, R. Charlotte...
Frontiers in Endocrinology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
15

Beneficial impact of Ac3IV, an AVP analogue acting specific..:

Mohan, Shruti ; Lafferty, Ryan ; Tanday, Neil...
PLOS ONE.  16 (2021)  12 - p. e0261608 , 2021
Link: https://doi.org/10.1371/..
 
1-15